BioMarin
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
BMRN Key Statistics
Stock Snapshot
The current BioMarin(BMRN) stock price is $63.95, with a market capitalization of 12.69B. The stock trades at a price-to-earnings (P/E) ratio of 23.76.
As of 2026-02-20, BioMarin(BMRN) stock has fluctuated between $62.55 and $63.97. The current price stands at $63.95, placing the stock +2.2% above today's low and -0.0% off the high.
The BioMarin(BMRN)'s current trading volume is 888.97K, compared to an average daily volume of 2.28M.
In the last year, BioMarin(BMRN) shares hit a 52-week high of $73.51 and a 52-week low of $50.76.
In the last year, BioMarin(BMRN) shares hit a 52-week high of $73.51 and a 52-week low of $50.76.
BMRN News
Wells Fargo raised the firm’s price target on BioMarin (BMRN) to $75 from $70 and keeps an Overweight rating on the shares. The firm thinks upcoming Transcon-CN...
Advertisement Why BioMarin Pharmaceutical (BMRN) is on investors’ radar BioMarin Pharmaceutical (BMRN) has drawn attention after a recent stretch of mixed ret...
